---
document_datetime: 2023-09-21 19:13:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/kineret-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: kineret-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 0.9755785
conversion_datetime: 2025-12-31 01:16:04.035436
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

For procedures finalised after 1 December 2003 please refer to module 8B

| Scope                                                                                                                                                                                                                                                 | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Extension of shelf life as foreseen at time of authorisation.                                                                                                                                                                                         | I-0001               | I                        | 07.06.02                            | 11.07.02                                 |
| Extension of shelf life or retest period of the active substance.                                                                                                                                                                                     | I-0002               | I                        | 08.07.02                            | -                                        |
| Changes to the prefilled syringe plunger stopper (change in the sterilisation dose range and removal of bioburden alert and limit levels) and to analytical methods.                                                                                  | II-0003              | II                       | 23.01.03                            | -                                        |
| Changes to amend the Package Leaflet to include three changes of address of the local representatives.                                                                                                                                                | N-0004               | N                        | 11.10.02                            | 23.10.02                                 |
| To amend sections 4.4, 4.5 and 4.8 of the SPC to introduce information on the concurrent use of anakinra with etanercept, ie clinical study results showing increased rate of serious infections and neutropenia with no increase in clinical benefit | II-0006              | II                       | 23.01.03                            | 23.04.03                                 |
| Change(s) to the manufacturing process for the active substance Change(s) to the test method(s) and/or specifications for the active substance Change(s) to the test method(s) and/or specifications for the finished product Quality changes         | II-0007              | II                       | 22.05.03                            | -                                        |
| Change(s) to the test method(s) and/or specifications for the finished product Change(s) to shelf-life or storage conditions                                                                                                                          | II-0008              | II                       | 20.11.03                            | -                                        |